Denmark· DK-28106737922
Carmustine "Stada"
A carmustine product containing carmustin, registered in Denmark by STADA Arzneimittel AG. The same ATC class is registered in 16 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Carmustine is registered in 16 of 19 countries.
Countries holding a registration under ATC L01AD01 (carmustine), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Carmustine · ATC L01AD01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- carmustin
- Manufacturer
- STADA Arzneimittel AG
- Country
- Denmark (DK)
- ATC code
- L01AD01
- ATC class
- Carmustine
- Defined daily dose
- 8.57 mg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106737922
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
253 interactions on record for carmustine.
Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Carmustine · interactions on record
253 records
- 36 severe
- 108 moderate
- 15 minor
- 94 info
Most severe, free to view
- CimetidineA02BA01severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- Nalidixic acidJ01MB02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L01AD01
Carmustine, as other registers publish it.
- FinlandBecenunBristol-Myers Squibb Ab
- CanadaBICNUMARCAN PHARMACEUTICALS INC
- CanadaBICNUMARCAN PHARMACEUTICALS INC
- SwitzerlandBiCNU 100 mg, Pulver und Lösungsmittel zur Herstellung einer InfusionslösungIDEOGEN AG
- United KingdomBiCNU 100mg powder and solvent for solution for infusion vialsBristol-Myers Squibb Pharmaceuticals Ltd
- FranceBICNU, poudre et solvant pour solution pour perfusionTILLOMED PHARMA (ALLEMAGNE)
- GermanyCarmubrisTillomed Pharma Gmbh
- DenmarkCarmustin "Waymade"Waymade B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d3988d68-1418-4744-9d9f-0fc25aaf3b01 GET /v1/drugs/d3988d68-1418-4744-9d9f-0fc25aaf3b01?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver og solvens til koncentrat til infusionsvæske, opløsning",
"source": "dkma",
"strength": "100 mg/ml",
"auth_role": "CMS",
"dk_drugid": "28106737922",
"substance": "carmustin",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": false,
"registration_date_serial": "45692"
}See everything about carmustine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.